-
Je něco špatně v tomto záznamu ?
Sex specific associations in genome wide association analysis of renal cell carcinoma
RS. Laskar, DC. Muller, P. Li, MJ. Machiela, Y. Ye, V. Gaborieau, M. Foll, JN. Hofmann, L. Colli, JN. Sampson, Z. Wang, D. Bacq-Daian, A. Boland, B. Abedi-Ardekani, G. Durand, F. Le Calvez-Kelm, N. Robinot, H. Blanche, E. Prokhortchouk, KG....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, metaanalýza, multicentrická studie, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
10124
Cancer Research UK - United Kingdom
R01 CA170298
NCI NIH HHS - United States
U01 CA155309
NCI NIH HHS - United States
PubMed Central od 2009 do Před 1 rokem
Europe PubMed Central od 2009 do Před 1 rokem
ProQuest Central od 2000-01-01 do Před 1 rokem
Open Access Digital Library od 1998-01-01
Health & Medicine (ProQuest) od 2000-01-01 do Před 1 rokem
Odkazy
PubMed
31231134
DOI
10.1038/s41431-019-0455-9
Knihovny.cz E-zdroje
- MeSH
- celogenomová asociační studie * MeSH
- genetická predispozice k nemoci * MeSH
- jednonukleotidový polymorfismus MeSH
- karcinom z renálních buněk epidemiologie genetika MeSH
- lidé MeSH
- lokus kvantitativního znaku MeSH
- nádory ledvin epidemiologie genetika MeSH
- odds ratio MeSH
- sexuální faktory MeSH
- výpočetní biologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
Renal cell carcinoma (RCC) has an undisputed genetic component and a stable 2:1 male to female sex ratio in its incidence across populations, suggesting possible sexual dimorphism in its genetic susceptibility. We conducted the first sex-specific genome-wide association analysis of RCC for men (3227 cases, 4916 controls) and women (1992 cases, 3095 controls) of European ancestry from two RCC genome-wide scans and replicated the top findings using an additional series of men (2261 cases, 5852 controls) and women (1399 cases, 1575 controls) from two independent cohorts of European origin. Our study confirmed sex-specific associations for two known RCC risk loci at 14q24.2 (DPF3) and 2p21(EPAS1). We also identified two additional suggestive male-specific loci at 6q24.3 (SAMD5, male odds ratio (ORmale) = 0.83 [95% CI = 0.78-0.89], Pmale = 1.71 × 10-8 compared with female odds ratio (ORfemale) = 0.98 [95% CI = 0.90-1.07], Pfemale = 0.68) and 12q23.3 (intergenic, ORmale = 0.75 [95% CI = 0.68-0.83], Pmale = 1.59 × 10-8 compared with ORfemale = 0.93 [95% CI = 0.82-1.06], Pfemale = 0.21) that attained genome-wide significance in the joint meta-analysis. Herein, we provide evidence of sex-specific associations in RCC genetic susceptibility and advocate the necessity of larger genetic and genomic studies to unravel the endogenous causes of sex bias in sexually dimorphic traits and diseases like RCC.
Brigham and Women's Hospital and VA Boston Boston MA USA
Brown University Providence RI USA
Cancer Prevention Program Fred Hutchinson Cancer Research Center Seattle WA USA
Carol Davila University of Medicine and Pharmacy Th Burghele Hospital Bucharest Romania
Dana Farber Cancer Institute Bostan MA USA
Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Computational Biology St Jude Children's Research Hospital Memphis TN USA
Department of Epidemiology Nofer Institute of Occupational Medicine Lodz Poland
Department of Public Health Section for Epidemiology Aarhus University Aarhus C Denmark
Department of Surgical and Perioperative Sciences Urology and Andrology Umeå University Umeå Sweden
Department of Urology University Hospital Dr D Misovic Clinical Center Belgrade Serbia
Dipartimento di Medicina Clinica e Chirurgia Federico 2 University Naples Italy
Division of Urology Spectrum Health Grand Rapids MI USA
Faculty of Medicine School of Public Health Imperial College London London UK
Fondation Jean Dausset Centre d'Etude du Polymorphisme Humain Paris France
Fred Hutchinson Cancer Research Center Seattle WA USA
Harvard T H Chan School of Public Health Boston MA USA
Hellenic Health Foundation Alexandroupoleos 23 Athens 11527 Greece
INSERM U946 Paris France CNRS UMR8200 Institute Gustave Roussy Villejuif France
Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
Institute of Pathology Medical school of Belgrade Belgrade Serbia
International Agency for Research on Cancer Lyon France
London School of Hygiene and Tropical Medicine University of London London UK
Max Planck Institute for Demographic Research Rostock Germany
McGill University and Genome Quebec Innovation Centre Montreal Quebec Canada
National Institute for Health and Welfare Helsinki Finland
National Institute of Public Health Bucharest Romania
National Public Health Institute Budapest Hungary
Regional Authority of Public Health in BanskaBystrica BanskaBystrica Slovakia
Russian N N Blokhin Cancer Research Centre Moscow Russian Federation
Sorbonne Université GRC no 5 ONCOTYPE URO AP HP Tenon Hospital Paris France CeRePP Paris France
The M Sklodowska Curie Cancer Center and Institute of Oncology Warsaw Poland
Van Andel Research Institute Center for Cancer Genomics and Quantitative Biology Grand Rapids MI USA
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023620
- 003
- CZ-PrNML
- 005
- 20201214130614.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41431-019-0455-9 $2 doi
- 035 __
- $a (PubMed)31231134
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Laskar, Ruhina S $u International Agency for Research on Cancer (IARC), Lyon, France.
- 245 10
- $a Sex specific associations in genome wide association analysis of renal cell carcinoma / $c RS. Laskar, DC. Muller, P. Li, MJ. Machiela, Y. Ye, V. Gaborieau, M. Foll, JN. Hofmann, L. Colli, JN. Sampson, Z. Wang, D. Bacq-Daian, A. Boland, B. Abedi-Ardekani, G. Durand, F. Le Calvez-Kelm, N. Robinot, H. Blanche, E. Prokhortchouk, KG. Skryabin, L. Burdett, M. Yeager, S. Radojevic-Skodric, S. Savic, L. Foretova, I. Holcatova, V. Janout, D. Mates, S. Rascu, A. Mukeria, D. Zaridze, V. Bencko, C. Cybulski, E. Fabianova, V. Jinga, J. Lissowska, J. Lubinski, M. Navratilova, P. Rudnai, B. Świątkowska, S. Benhamou, G. Cancel-Tassin, O. Cussenot, A. Trichopoulou, E. Riboli, K. Overvad, S. Panico, B. Ljungberg, RT. Sitaram, GG. Giles, RL. Milne, G. Severi, F. Bruinsma, T. Fletcher, K. Koppova, SC. Larsson, A. Wolk, RE. Banks, PJ. Selby, DF. Easton, P. Pharoah, G. Andreotti, LE. Beane Freeman, S. Koutros, D. Albanes, S. Männistö, S. Weinstein, PE. Clark, TL. Edwards, L. Lipworth, H. Carol, ML. Freedman, MM. Pomerantz, E. Cho, P. Kraft, MA. Preston, KM. Wilson, J. Michael Gaziano, HD. Sesso, A. Black, ND. Freedman, WY. Huang, JG. Anema, RJ. Kahnoski, BR. Lane, SL. Noyes, D. Petillo, BT. Teh, U. Peters, E. White, GL. Anderson, L. Johnson, J. Luo, WH. Chow, LE. Moore, TK. Choueiri, C. Wood, M. Johansson, JD. McKay, KM. Brown, N. Rothman, MG. Lathrop, JF. Deleuze, X. Wu, P. Brennan, SJ. Chanock, MP. Purdue, G. Scelo,
- 520 9_
- $a Renal cell carcinoma (RCC) has an undisputed genetic component and a stable 2:1 male to female sex ratio in its incidence across populations, suggesting possible sexual dimorphism in its genetic susceptibility. We conducted the first sex-specific genome-wide association analysis of RCC for men (3227 cases, 4916 controls) and women (1992 cases, 3095 controls) of European ancestry from two RCC genome-wide scans and replicated the top findings using an additional series of men (2261 cases, 5852 controls) and women (1399 cases, 1575 controls) from two independent cohorts of European origin. Our study confirmed sex-specific associations for two known RCC risk loci at 14q24.2 (DPF3) and 2p21(EPAS1). We also identified two additional suggestive male-specific loci at 6q24.3 (SAMD5, male odds ratio (ORmale) = 0.83 [95% CI = 0.78-0.89], Pmale = 1.71 × 10-8 compared with female odds ratio (ORfemale) = 0.98 [95% CI = 0.90-1.07], Pfemale = 0.68) and 12q23.3 (intergenic, ORmale = 0.75 [95% CI = 0.68-0.83], Pmale = 1.59 × 10-8 compared with ORfemale = 0.93 [95% CI = 0.82-1.06], Pfemale = 0.21) that attained genome-wide significance in the joint meta-analysis. Herein, we provide evidence of sex-specific associations in RCC genetic susceptibility and advocate the necessity of larger genetic and genomic studies to unravel the endogenous causes of sex bias in sexually dimorphic traits and diseases like RCC.
- 650 _2
- $a karcinom z renálních buněk $x epidemiologie $x genetika $7 D002292
- 650 _2
- $a výpočetní biologie $7 D019295
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 12
- $a celogenomová asociační studie $7 D055106
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory ledvin $x epidemiologie $x genetika $7 D007680
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a odds ratio $7 D016017
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a lokus kvantitativního znaku $7 D040641
- 650 _2
- $a sexuální faktory $7 D012737
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Muller, David C $u Faculty of Medicine, School of Public Health, Imperial College London, London, UK.
- 700 1_
- $a Li, Peng $u Max Planck Institute for Demographic Research, Rostock, Germany.
- 700 1_
- $a Machiela, Mitchell J $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Ye, Yuanqing $u Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- 700 1_
- $a Gaborieau, Valerie $u International Agency for Research on Cancer (IARC), Lyon, France.
- 700 1_
- $a Foll, Matthieu $u International Agency for Research on Cancer (IARC), Lyon, France.
- 700 1_
- $a Hofmann, Jonathan N $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Colli, Leandro $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Sampson, Joshua N $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Wang, Zhaoming $u Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
- 700 1_
- $a Bacq-Daian, Delphine $u Centre National de Recherche en Génomique Humaine, , Institut de biologie François Jacob, CEA, Evry, France.
- 700 1_
- $a Boland, Anne $u Centre National de Recherche en Génomique Humaine, , Institut de biologie François Jacob, CEA, Evry, France.
- 700 1_
- $a Abedi-Ardekani, Behnoush $u International Agency for Research on Cancer (IARC), Lyon, France.
- 700 1_
- $a Durand, Geoffroy $u International Agency for Research on Cancer (IARC), Lyon, France.
- 700 1_
- $a Le Calvez-Kelm, Florence $u International Agency for Research on Cancer (IARC), Lyon, France.
- 700 1_
- $a Robinot, Nivonirina $u International Agency for Research on Cancer (IARC), Lyon, France.
- 700 1_
- $a Blanche, Helene $u Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.
- 700 1_
- $a Prokhortchouk, Egor $u Center 'Bioengineering' of the Russian Academy of Sciences, Moscow, Russian Federation. Kurchatov Scientific Center, Moscow, Russian Federation.
- 700 1_
- $a Skryabin, Konstantin G $u Center 'Bioengineering' of the Russian Academy of Sciences, Moscow, Russian Federation. Kurchatov Scientific Center, Moscow, Russian Federation.
- 700 1_
- $a Burdett, Laurie $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Yeager, Meredith $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Radojevic-Skodric, Sanja $u Institute of Pathology, Medical school of Belgrade, Belgrade, Serbia.
- 700 1_
- $a Savic, Slavisa $u Department of Urology, University Hospital "Dr D. Misovic" Clinical Center, Belgrade, Serbia.
- 700 1_
- $a Foretova, Lenka $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- 700 1_
- $a Holcatova, Ivana $u 2nd Faculty of Medicine, Institute of Public Health and Preventive Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Janout, Vladimir $u Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic. Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
- 700 1_
- $a Mates, Dana $u National Institute of Public Health, Bucharest, Romania.
- 700 1_
- $a Rascu, Stefan $u Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
- 700 1_
- $a Mukeria, Anush $u Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
- 700 1_
- $a Zaridze, David $u Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
- 700 1_
- $a Bencko, Vladimir $u First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.
- 700 1_
- $a Cybulski, Cezary $u International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
- 700 1_
- $a Fabianova, Eleonora $u Regional Authority of Public Health in BanskaBystrica, BanskaBystrica, Slovakia.
- 700 1_
- $a Jinga, Viorel $u Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
- 700 1_
- $a Lissowska, Jolanta $u The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.
- 700 1_
- $a Lubinski, Jan $u International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
- 700 1_
- $a Navratilova, Marie $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- 700 1_
- $a Rudnai, Peter $u National Public Health Institute, Budapest, Hungary.
- 700 1_
- $a Świątkowska, Beata $u Department of Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland.
- 700 1_
- $a Benhamou, Simone $u INSERM U946, Paris, France. CNRS UMR8200, Institute Gustave Roussy, Villejuif, France.
- 700 1_
- $a Cancel-Tassin, Geraldine $u Sorbonne Université, GRC no. 5, ONCOTYPE-URO, AP-HP, Tenon Hospital, Paris, France. CeRePP, Paris, France.
- 700 1_
- $a Cussenot, Olivier $u Sorbonne Université, GRC no. 5, ONCOTYPE-URO, AP-HP, Tenon Hospital, Paris, France. CeRePP, Paris, France.
- 700 1_
- $a Trichopoulou, Antonia $u Hellenic Health Foundation, Alexandroupoleos 23, Athens, 11527, Greece.
- 700 1_
- $a Riboli, Elio $u Faculty of Medicine, School of Public Health, Imperial College London, London, UK.
- 700 1_
- $a Overvad, Kim $u Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus C, Denmark.
- 700 1_
- $a Panico, Salvatore $u Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
- 700 1_
- $a Ljungberg, Borje $u Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
- 700 1_
- $a Sitaram, Raviprakash T $u Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
- 700 1_
- $a Giles, Graham G $u Cancer Epidemiology & Intelligence Division, Cancer Council of Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville Victoria, 3010, Australia.
- 700 1_
- $a Milne, Roger L $u Cancer Epidemiology & Intelligence Division, Cancer Council of Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville Victoria, 3010, Australia.
- 700 1_
- $a Severi, Gianluca $u Cancer Epidemiology & Intelligence Division, Cancer Council of Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia. Inserm U1018, Center for Research in Epidemiology and Population Health (CESP), Facultés de Medicine, Université Paris-Saclay, Université Paris-Sud, UVSQ, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France.
- 700 1_
- $a Bruinsma, Fiona $u Cancer Epidemiology & Intelligence Division, Cancer Council of Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.
- 700 1_
- $a Fletcher, Tony $u London School of Hygiene and Tropical Medicine, University of London, London, UK.
- 700 1_
- $a Koppova, Kvetoslava $u Regional Authority of Public Health in BanskaBystrica, BanskaBystrica, Slovakia.
- 700 1_
- $a Larsson, Susanna C $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Wolk, Alicja $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Banks, Rosamonde E $u Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, UK.
- 700 1_
- $a Selby, Peter J $u Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, UK.
- 700 1_
- $a Easton, Douglas F $u Department of Oncology, University of Cambridge, Cambridge, UK. Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
- 700 1_
- $a Pharoah, Paul $u Department of Oncology, University of Cambridge, Cambridge, UK. Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
- 700 1_
- $a Andreotti, Gabriella $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Beane Freeman, Laura E $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Koutros, Stella $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Albanes, Demetrius $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Männistö, Satu $u National Institute for Health and Welfare, Helsinki, Finland.
- 700 1_
- $a Weinstein, Stephanie $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Clark, Peter E $u Vanderbilt-Ingram Cancer Center, Nasville, TN, USA.
- 700 1_
- $a Edwards, Todd L $u Vanderbilt-Ingram Cancer Center, Nasville, TN, USA.
- 700 1_
- $a Lipworth, Loren $u Vanderbilt-Ingram Cancer Center, Nasville, TN, USA.
- 700 1_
- $a Carol, Hallie $u Dana-Farber Cancer Institute, Bostan, MA, USA.
- 700 1_
- $a Freedman, Matthew L $u Dana-Farber Cancer Institute, Bostan, MA, USA.
- 700 1_
- $a Pomerantz, Mark M $u Dana-Farber Cancer Institute, Bostan, MA, USA.
- 700 1_
- $a Cho, Eunyoung $u Brown University, Providence, RI, USA.
- 700 1_
- $a Kraft, Peter $u Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- 700 1_
- $a Preston, Mark A $u Brigham and Women's Hospital and VA Boston, Boston, MA, USA.
- 700 1_
- $a Wilson, Kathryn M $u Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- 700 1_
- $a Michael Gaziano, J $u Brigham and Women's Hospital and VA Boston, Boston, MA, USA.
- 700 1_
- $a Sesso, Howard D $u Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- 700 1_
- $a Black, Amanda $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Freedman, Neal D $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Huang, Wen-Yi $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Anema, John G $u Division of Urology, Spectrum Health, Grand Rapids, MI, USA.
- 700 1_
- $a Kahnoski, Richard J $u Division of Urology, Spectrum Health, Grand Rapids, MI, USA.
- 700 1_
- $a Lane, Brian R $u Division of Urology, Spectrum Health, Grand Rapids, MI, USA. College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
- 700 1_
- $a Noyes, Sabrina L $u Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, MI, USA.
- 700 1_
- $a Petillo, David $u Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, MI, USA.
- 700 1_
- $a Teh, Bin Tean $u Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, MI, USA.
- 700 1_
- $a Peters, Ulrike $u Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- 700 1_
- $a White, Emily $u Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- 700 1_
- $a Anderson, Garnet L $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- 700 1_
- $a Johnson, Lisa $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- 700 1_
- $a Luo, Juhua $u Department of Epidemiology and Biostatistics, School of Public Health Indiana University Bloomington, Bloomington, IN, USA.
- 700 1_
- $a Chow, Wong-Ho $u Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- 700 1_
- $a Moore, Lee E $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Choueiri, Toni K $u Dana-Farber Cancer Institute, Bostan, MA, USA.
- 700 1_
- $a Wood, Christopher $u Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- 700 1_
- $a Johansson, Mattias $u International Agency for Research on Cancer (IARC), Lyon, France.
- 700 1_
- $a McKay, James D $u International Agency for Research on Cancer (IARC), Lyon, France.
- 700 1_
- $a Brown, Kevin M $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Rothman, Nathaniel $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Lathrop, Mark G $u McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada.
- 700 1_
- $a Deleuze, Jean-Francois $u Centre National de Recherche en Génomique Humaine, , Institut de biologie François Jacob, CEA, Evry, France. Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, Paris, France.
- 700 1_
- $a Wu, Xifeng $u Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- 700 1_
- $a Brennan, Paul $u International Agency for Research on Cancer (IARC), Lyon, France.
- 700 1_
- $a Chanock, Stephen J $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Purdue, Mark P $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MD, USA.
- 700 1_
- $a Scelo, Ghislaine $u International Agency for Research on Cancer (IARC), Lyon, France. scelog@iarc.fr.
- 773 0_
- $w MED00005019 $t European journal of human genetics : EJHG $x 1476-5438 $g Roč. 27, č. 10 (2019), s. 1589-1598
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31231134 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214130610 $b ABA008
- 999 __
- $a ok $b bmc $g 1595939 $s 1114296
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 27 $c 10 $d 1589-1598 $e 20190623 $i 1476-5438 $m European journal of human genetics $n Eur J Hum Genet $x MED00005019
- GRA __
- $a 10124 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a R01 CA170298 $p NCI NIH HHS $2 United States
- GRA __
- $a U01 CA155309 $p NCI NIH HHS $2 United States
- LZP __
- $a Pubmed-20201125